Clinical trial · Observational
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval. Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Pharmaceutical group
- description
- Patients in pharmaceutical castration treatment for advanced prostate cancer
- label
- Surgical group
- description
- Patients having undergone surgical castration treatment for advanced prostate cancer
Primary outcomes (1)
- measure
- Preferred treatment/control frequency for patients with advanced prostate cancer
- timeFrame
- Up to 1 year
- description
- Preferred treatment frequency is assessed by patient answers to the question: "If treatments were equally effective from a medical standpoint - How often would you then prefer to receive treatment"
Secondary outcomes (3)
- measure
- Treatment satisfaction
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * A diagnosis of advanced prostate cancer * Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy) Exclusion Criteria: * Inability to read/write Danish
References
Publications (0)
Data not yet available